Business overview
TrustScore Analysis
Our preliminary analysis has revealed key insights about ESCO LIFESCIENCES INVESTMENTS PTE. LTD.'s performance and market presence. Here's a summary of our findings:
Strengths Identified
- Has been operational for a few years
Areas of Concern
How your TrustScore is determined
Claim your business profile to update business details and engage with customers.
Company News
Recent news articles and media coverage about ESCO LIFESCIENCES INVESTMENTS PTE. LTD..
- 1. Esco Lifesciences raises US$200 million ahead of potential listing The Singapore-based company, which supplies life sciences tools for the healthcare industry, got backing from GIC in its Series A round, according to a source. The funding was led by US-based healthcare investment firm Vivo Capital and Denmark-based life science investor Novo Holdings, the venture arm of Novo Nordisk Foundation.1. Esco Lifesciences raises US$200 million ahead of potential listing The Singapore-based company, which supplies life sciences tools for the healthcare industry, got backing from GIC in its Series A round, according to a source. The funding was led by US-based healthcare investment firm Vivo Capital and Denmark-based life science investor Novo Holdings, the venture arm of Novo Nordisk Foundation.23 Feb 2025
- Singapore Biopharma Manufacturer Raises $200 Million Series A | BioSpaceSingapore-based Esco Lifesciences closed a $200 million oversubscribed Series A financing and crossover round that will enable the company that provides life sciences tools and services to expand its toehold in China and the United States. Esco is a manufacturer of laboratory and biopharma equipment and IVF medical devices. The company has four different divisions, Scientific, Medical, Healthcare, and Aster, which offers “mission-critical equipment and advanced solutions” to laboratories, clinics, and bio-pharma production sites in over 100 countries. The company employs more than 1,300 people across the globe. It has offices in more than 100 companies, including eight manufacturing and R&D hubs in the US, Europe, the UK, China, and Singapore. The financing round is the largest private fundraising round by an Asia-based life sciences tools company, Esco said in its announcement.23 Feb 2025
- Novo Holdings, Vivo lead a record $200M raise for a Singapore-based tools player with plans for a Boston hub, new dealsClose to a year after putting a foot down in Singapore, Novo Holdings has spotted an Asia-based player worth betting a big chunk of its “patient capital” on. The Danish group is co-leading a $200 million Series A for Esco Lifesciences Group — setting a new record for life sciences tools companies in the region, according to the investor, and funding a sprint toward “Esco 3.0,” where cell and gene therapy process development and manufacturing will loom large.23 Feb 2025
- S'pore lab firm raises $265m from backers including GICEsco Lifesciences Group, a Singapore firm that pivoted from washing laboratory gowns to making high-tech equipment, has raised US$200 million (S$265 million) from some of the world's biggest healthcare investors, paving the way for a possible listing in Hong Kong this year. The funding round, led by Danish investment giant Novo Holdings and US investor Vivo Capital, also included Chinese sovereign wealth fund China Investment, according to a statement from Esco. Other new backers include Singapore's sovereign wealth fund GIC, with the fund raising giving the company a valuation of US$800 million, according to people familiar with the matter. The sources asked not to be identified as the details are not public.23 Feb 2025
- Novo, GIC back Singapore lab firm in US$200 million funding roundEsco Lifesciences Group, a Singapore firm that pivoted from washing lab gowns to making high-tech equipment, has raised US$200 million (S$265 million) from some of the world's biggest healthcare investors, paving the way for a possible listing in Hong Kong this year. The funding round led by Danish investment giant Novo Holdings and US investor Vivo Capital also included Chinese sovereign wealth fund China Investment, according to a statement from Esco. Other new backers include Singapore's GIC, with the fund raising giving the company a valuation of US$800 million, according to people familiar with the matter. The sources asked not to be identified as the details are not public.23 Feb 2025
Profile Activity for ESCO LIFESCIENCES INVESTMENTS PTE. LTD.
Analytics and engagement metrics from recent Scam.SG visitor traffic patterns and profile interactions over the past 14 days.
Steady
Comparable to other Other Holding Companies companies
Public Preview of ESCO LIFESCIENCES INVESTMENTS PTE. LTD.
This is only a preview of the TrustScore results for ESCO LIFESCIENCES INVESTMENTS PTE. LTD., showcasing a few facets of its business that we have analysed.
Foundational Stage
A young brand or company in the early stage of organisation structures, framework, processes, workflow, systems.
- Defining Core Identity: ESCO LIFESCIENCES INVESTMENTS PTE. LTD. is likely still defining its mission, vision and values.
- Building Awareness: Working to establish recognition among its target audience and identifying opportunities in the other holding companies sector.
- Limited Resources: Often operating with a small team, budget, or customer base. May not yet have a strong social media presence or widespread advertising.
- Focus on Differentiation: Still trying to carve out a unique position in the market, or have a unique selling proposition. They are gathering feedback and iterating on their offerings.
- These potential brands often represent innovation and creativity.
- They often bring fresh ideas to the market and have the opportunity to grow into influential players if they successfully establish their identity and connect with their audience.
The company's address is unique, providing a credible and exclusive business location. ESCO LIFESCIENCES INVESTMENTS PTE. LTD. has been operational for a few years, showing some level of stability. While it shows some level of stability, it may still be in the process of establishing its reputation and credibility.
ESCO LIFESCIENCES INVESTMENTS PTE. LTD. has no presence on career platforms and provides no public information about its work environment or employee satisfaction. This lack of transparency may indicate less focus on employee well-being or difficulty in attracting talent, potentially impacting ESCO LIFESCIENCES INVESTMENTS PTE. LTD.'s long-term success.
The company is not on the MAS Enforcement List, which is a positive indicator of its compliance with financial regulations. The company is not blacklisted by CaseTrust, which is a positive indicator of its credibility.
The company has no official business profile on major search engines. This absence makes it difficult for potential customers to verify the company's legitimacy or get in touch, potentially raising suspicions about its credibility. ESCO LIFESCIENCES INVESTMENTS PTE. LTD. may not have accessible contact information online, which dilutes engagement and credibility.
Unlock Complete Analysis
Get access to all metrics and detailed risk assessments for ESCO LIFESCIENCES INVESTMENTS PTE. LTD.
TrustScore Last Scanned:
20 Mar 2026ESCO LIFESCIENCES INVESTMENTS PTE. LTD. Job Openings
Explore available job positions and career opportunities currently offered by ESCO LIFESCIENCES INVESTMENTS PTE. LTD..
No Job Openings Available
ESCO LIFESCIENCES INVESTMENTS PTE. LTD. doesn't have any active job listings at the moment. Check back later for new opportunities.
Related Business Entities to ESCO LIFESCIENCES INVESTMENTS PTE. LTD.
Explore Singapore-registered businesses that share similar characteristics with ESCO LIFESCIENCES INVESTMENTS PTE. LTD., including companies with related names, operating in the same industry sectors, or located in nearby geographical areas.
Similar Business Names
Companies with names similar to ESCO LIFESCIENCES INVESTMENTS PTE. LTD.
Nearby Businesses
Businesses located in CHANGI SOUTH STREET 1, Singapore 486779
Similar Principal Activity
Companies with the same primary SSIC code: 64202
Frequently Asked Questions About ESCO LIFESCIENCES INVESTMENTS PTE. LTD.
Common questions and answers to help you learn more about ESCO LIFESCIENCES INVESTMENTS PTE. LTD.
ESCO LIFESCIENCES INVESTMENTS PTE. LTD. has been in operation for 6 years since its incorporation in 17 November 2020 based on ACRA registration date. The business is registered with ACRA (Accounting and Corporate Regulatory Authority) under UEN 202037114H.
Suggested reads for this industry
Hand-picked scam prevention resources relevant to Other holding companies
Join the Scam.SG community
Share your experience to help others make confident decisions. Follow us for the latest scam prevention tips and community updates.